Literature DB >> 28875342

Undiagnosed renal sarcoidosis in a patient with chronic interstitial nephritis.

Wenfang Dong1,2, Bin Qiu3, Hongfeng Liu4, Leren He5.   

Abstract

A 53-year-old female was admitted to hospital, with acute elevation of SCr and hypercalcemia, on a 5-year history of chronic interstitial nephritis and stage III chronic kidney disease (CKD). Extensive workup failed to yield a definitive diagnosis concerning the cause of the disorder. Intense uptake of 18F-FDG in the spleen and liver was detected by PET/CT imaging with negative angiotensin-converting enzyme (ACE) in serum. The spleen and the hypermetabolism nodules of the liver were resected for histopathologic examination and turned out to be noncaseating granulomas, likely sarcoidosis. Combined with clinical features, the final diagnosis for this patient was sarcoidosis, involving the kidneys, spleen, liver, and lungs.

Entities:  

Keywords:  Acute kidney injury (AKI); Interstitial nephritis; Sarcoidosis

Mesh:

Year:  2017        PMID: 28875342     DOI: 10.1007/s10067-017-3801-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  17 in total

1.  Acute kidney injury caused by sarcoid granulomatous interstitial nephritis without extrarenal manifestations.

Authors:  Hiroaki Kikuchi; Takayasu Mori; Tatemitsu Rai; Shinichi Uchida
Journal:  CEN Case Rep       Date:  2015-03-05

Review 2.  Sarcoidosis.

Authors:  Adriana A Bonfioli; Fernando Orefice
Journal:  Semin Ophthalmol       Date:  2005 Jul-Sep       Impact factor: 1.975

Review 3.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

4.  ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis.

Authors:  Adrian Kruit; Jan C Grutters; Wim B M Gerritsen; Snjezana Kos; Will K W H Wodzig; Jules M M van den Bosch; Henk J T Ruven
Journal:  Respir Med       Date:  2006-08-09       Impact factor: 3.415

5.  Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.

Authors:  F Cambien; F Alhenc-Gelas; B Herbeth; J L Andre; R Rakotovao; M F Gonzales; J Allegrini; C Bloch
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

6.  The clinical characteristics of sarcoid arthropathy based on a prospective cohort study.

Authors:  Senol Kobak; Fidan Sever; Ozan Usluer; Tuncay Goksel; Mehmet Orman
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-09-23       Impact factor: 5.346

Review 7.  Etiologies of Sarcoidosis.

Authors:  Edward S Chen; David R Moller
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 8.  Sarcoidosis vs. Sarcoid-like reactions: The Two Sides of the same Coin?

Authors:  Georgi Tchernev; Claudio Tana; Cosima Schiavone; José-Carlos Cardoso; Julian Ananiev; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-03-25

9.  Evaluation of Wegener's granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Kimiteru Ito; Ryogo Minamimoto; Hiroyuki Yamashita; Setsuko Yoshida; Miyako Morooka; Momoko Okasaki; Akio Mimori; Kazuo Kubota
Journal:  Ann Nucl Med       Date:  2012-12-16       Impact factor: 2.668

10.  Renal sarcoidosis with normal serum vitamin D and refractory hypercalcemia.

Authors:  Abdulkadir Unsal; Taner Basturk; Yener Koc; Tamer Sakacı; Elbis Ahbap; Aysim Ozagarı; Ayşe Sinangil Arar; Cüneyt Akgül; Mustafa Sevınc
Journal:  Int Urol Nephrol       Date:  2012-07-25       Impact factor: 2.266

View more
  1 in total

1.  Hypercalciuria may predict better response to immunosuppressive therapy in renal sarcoidosis: a case series.

Authors:  Tao Zhao; Xiaojuan Yu; Suxia Wang; Li Yang; Tao Su
Journal:  J Nephrol       Date:  2022-06-13       Impact factor: 3.902

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.